Boehringer Ingelheim Pharmaceuticals, Inc.
Patent Owner
Stats
- 265 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 28, 2015 most recent publication
Details
- 265 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 6,110 Total Citation Count
- May 29, 1984 Earliest Filing
- 103 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8741897 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofSep 22, 04Jun 03, 14[A61K, C07D, A61P]
8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereofApr 25, 06Jul 03, 12[A61K, C07D]
7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereofJul 20, 05Apr 26, 11[C07D]
7914770 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellantsMar 19, 04Mar 29, 11[A61K]
7795272 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereofMar 04, 05Sep 14, 10[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0178,184 T CELL PROTEINS AND NUCLEOTIDES ENCODING THE SAMEAbandonedMar 29, 12Jul 12, 12[G01N, C07K]
2012/0135,401 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory DiseaseAbandonedMar 23, 11May 31, 12[C12Q]
2011/0301,201 DABIGATRAN FOR PERCUTANEOUS INTERVENTIONAL CARDIAC CATHETERISATIONAbandonedAug 17, 09Dec 08, 11[A61K, A61P]
2010/0234,347 Substituted Pteridines substituted with a Four-Membered HeterocycleAbandonedMay 15, 07Sep 16, 10[A61K, C07D, A61P]
2010/0136,550 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory DiseaseAbandonedSep 25, 09Jun 03, 10[C12Q]
2010/0119,506 Effectors of PAR-2 Activation and Their Use in the Modulation of InflammationAbandonedJul 30, 09May 13, 10[A61K, A61P, C07K]
2009/0110,669 METHODS FOR IMPROVING CELL LINE ACTIVITY IN IMMUNOISOLATION DEVICESAbandonedJan 05, 09Apr 30, 09[A61K, C12N, A61P]
2009/0099,159 Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide CompoundsAbandonedDec 17, 08Apr 16, 09[A61K, C07D, A61P]
2009/0088,571 Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amidesAbandonedDec 05, 08Apr 02, 09[C07D, C07C]
2009/0035,321 Intercellular adhesion molecules and their binding ligandsAbandonedDec 04, 06Feb 05, 09[A61K, C07H, C12Q, C07K]
2007/0099,949 Method for Improving the Ability of Patients Suffering from Lung Diseases to Participate In and Benefit from Pulmonary Rehabilitation ProgramsAbandonedAug 31, 06May 03, 07[A61K]
2007/0032,403 Crystal structure of the ITK kinase domainAbandonedDec 23, 04Feb 08, 07[A61K, C12N, G01N, G06F]
2007/0009,498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell linesAbandonedJan 17, 06Jan 11, 07[A61K, C07H, C12P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.